---
title: "Akero Therapeutics (AKRO.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AKRO.US/norm.md"
symbol: "AKRO.US"
name: "Akero Therapeutics"
parent: "https://longbridge.com/en/quote/AKRO.US.md"
datetime: "2026-05-21T14:16:53.332Z"
locales:
  - [en](https://longbridge.com/en/quote/AKRO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AKRO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AKRO.US/norm.md)
---

# Akero Therapeutics (AKRO.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.9946 | -0.8627 | -0.8992 | -0.9922 | -1.05 |
| ROE | -32.90% | -26.74% | -30.85% | -37.64% | -37.86% |
| Revenue | - | - | - | - | - |
| Net income | -81.57M | -70.50M | -70.72M | -70.02M | -72.70M |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.01B | 1.11B | 1.16B | 825.89M | 817.55M |
| Leverage | 1.05 | 1.08 | 1.07 | 1.10 | 1.11 |
| BVPS | 11.95 | 12.84 | 13.60 | 10.36 | 10.61 |
| Turnover | - | - | - | - | - |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -67.17M | -48.25M | -67.66M | -67.09M | -70.42M |
| Investing CF | 56.78M | 79.34M | -482.18M | 15.27M | 73.07M |
| Financing CF | -34.03M | 3.43M | 395.53M | 75.99M | 3.07M |
| Free CF | -40.82M | -25.80M | -45.31M | -42.78M | -45.31M |